LexDanaLexDanabeta
Inventor

Jochen PENDZIALEK

Inventor
DE

Overview

5→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 5 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
C07KPeptides29%
A61KPreparations for medical, dental or toiletry purposes24%
C12NMicroorganisms or enzymes18%
PatentTitleYear
12,435,139Antibody constructs for DLL3 and CD3202512,304,952Antibody constructs for DLL3 and CD3202512,258,404Bispecific antibody construct directed to MUC17 and CD3202511,591,396Antibody constructs for DLL3 and CD3202311,447,567Antibody constructs for FLT3 and CD32022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to AMGEN RES MUNICH GMBH (5)· patent assignee history
2022–2025Based in DE· patent location history
2025Patents assigned to AMGEN INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
AMGEN RES MUNICH GMBH52022–2025
AMGEN INC12025
Locations
LocationPatentsSpan
DE52022–2025